Evidence map›Paper›PMID 30127527›Full record

ArticleNature genetics2018

Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk.

Stephane E Castel, Alejandra Cervera, Pejman Mohammadi, François Aguet, Ferran Reverter, Aaron Wolman, Roderic Guigo, Ivan Iossifov, Ana Vasileva, Tuuli Lappalainen

Abstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Revisiting the Genetics of Hypophosphatasia.Journal of inherited metabolic disease · 2025
    Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephane E CastelNew York Genome Center, New York, NY, USA. scastel@nygenome.org.ORCID http://orcid.org/0000-0002-0707-2133
Alejandra CerveraNew York Genome Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-6274-1168
Pejman MohammadiNew York Genome Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-4457-8552
François AguetBroad Institute of MIT and Harvard, Cambridge, USA.ORCID http://orcid.org/0000-0001-9414-300X
Ferran ReverterCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Aaron WolmanNew York Genome Center, New York, NY, USA.
Roderic GuigoCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-5738-4477
Ivan IossifovNew York Genome Center, New York, NY, USA.
Ana VasilevaNew York Genome Center, New York, NY, USA.
Tuuli LappalainenNew York Genome Center, New York, NY, USA. tlappalainen@nygenome.org.

Funding

New York Center for Collaborative Research In Common Disease Genomics: Genome Aggregation and Joint Variant Calling for CCDG Freeze2UM1HG008901 · NHGRI · NEW YORK GENOME CENTER · PI MANIATIS, THOMAS P, WIGLER, MICHAEL H · 2016 to 2020
$56.6M
PAGES: Physical Activity Genomics, Epigenomics/transcriptomics SiteU24DK112331 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI STUART C. SEALFON, Martin John Walsh · 2017 to 2026
$18.5M
Statistical models for fine-mapping and interpretation of schizophrenia-associated lociR01MH106842 · NIMH · NEW YORK GENOME CENTER · PI BUSSEMAKER, HARMEN J, LAPPALAINEN, TUULI · 2015 to 2024
$5.0M
Methods for high-resolution analysis of genetic effects on gene expressionR01MH101814 · NIMH · UNIVERSITY OF GENEVA · PI BUSTAMANTE, CARLOS DANIEL, DERMITZAKIS, EMMANOUIL · 2013 to 2016
$2.3M
Regulatory modifiers of coding variant penetrance via haplotype epistasis in human populations and diseasesR01GM122924 · NIGMS · NEW YORK GENOME CENTER · PI LAPPALAINEN, TUULI · 2017 to 2021
$1.7M
Characterizing genetic, longitudinal, and developmental effects on the transcriptome using a novel non-invasive RNA-sequencing methodK99HG009916 · NHGRI · NEW YORK GENOME CENTER · PI CASTEL, STEPHANE EMILE · 2018 to 2018
$95k
NHGRI NIH HHS K99 HG009916NHGRI NIH HHS UM1 HG008901NIDDK NIH HHS U24 DK112331NIGMS NIH HHS R01 GM122924NIMH NIH HHS R01 MH101814NIMH NIH HHS R01 MH106842
6 · The paper itself

Abstract

Coding variants represent many of the strongest associations between genotype and phenotype; however, they exhibit inter-individual differences in effect, termed 'variable penetrance'. Here, we study how cis-regulatory variation modifies the penetrance of coding variants. Using functional genomic and genetic data from the Genotype-Tissue Expression Project (GTEx), we observed that in the general population, purifying selection has depleted haplotype combinations predicted to increase pathogenic coding variant penetrance. Conversely, in cancer and autism patients, we observed an enrichment of penetrance increasing haplotype configurations for pathogenic variants in disease-implicated genes, providing evidence that regulatory haplotype configuration of coding variants affects disease risk. Finally, we experimentally validated this model by editing a Mendelian single-nucleotide polymorphism (SNP) using CRISPR/Cas9 on distinct expression haplotypes with the transcriptome as a phenotypic readout. Our results demonstrate that joint regulatory and coding variant effects are an important part of the genetic architecture of human traits and contribute to modified penetrance of disease-causing variants.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideCRISPR-Cas SystemsDiseaseGenome, HumanHaplotypesHumansPhenotypeQuantitative Trait LociTranscriptome

Identifiers

PMID30127527
PMCPMC6119105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.